Compare Koninklijke Philips NV (PHG) vs Wendys Co (WEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Koninklijke Philips NV vs Wendys Co — how do they compare? Koninklijke Philips NV trades at $24.24 (market cap $23.52B), while Wendys Co trades at $6.23 (market cap $1.19B). The key difference: Koninklijke Philips NV is far larger — about 19.8× Wendys Co's market cap, and Wendys Co pays the higher dividend (4.49%). Which is the better fit depends on your goals — on Pluang, investors hold Koninklijke Philips NV for 84 Days and Wendys Co for 77 Days on average.
| PHG | WEN | |
|---|---|---|
Market Cap | $23.52B | $1.19B |
Volume | 1,635,069 | 5,622,905 |
Sector | Health | Consumer Cyclical |
52-Week High | $32.91 | $9.33 |
52-Week Low | $23.81 | $6.10 |
Typical Hold Time | 84 Days | 77 Days |
Enterprise Value | $29.87B | $4.92B |
Dividend Yield | 4.17% | 4.49% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PHG trades at $24.30, up 0.87% with a bearish technical signal despite recent earnings beats. The company shows improving fundamentals with net income turning positive to $895M in 2025 after previous losses, supported by strong cash flow generation. Recent news highlights product innovations including new CT systems and AI healthcare advancements, while institutional ownership shows mixed activity.
The outlook remains cautious with analyst consensus at Hold (63.64%) despite positive earnings momentum. Key risks include cybersecurity threats and competitive pressures in health technology. The stock presents a recovery opportunity but requires monitoring of execution risks and market sentiment shifts.
WEN trades at $6.22, up 1.8% today, but remains near multi-year lows amid bearish technical signals and fundamental pressures. The stock shows low valuation multiples (P/E 9.45, P/S 0.54) and a high ROE of 108.04%, yet faces declining net income margins (7.58% in 2025) and negative sentiment from recent franchisee bankruptcies. Earnings have consistently beaten estimates, but same-store sales declines and high debt levels ($2.66B long-term) weigh on investor confidence.
The outlook is cautious; while valuation appears cheap and dividend yield offers income, competitive pressures, shrinking sales, and leveraged balance sheet pose significant risks. Analyst consensus is 'Hold' with a $7.58 price target, suggesting limited upside without operational turnaround under new leadership.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Koninklijke Philips NV
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →About Wendys Co
The Wendy's Company is the second-largest burger quick-service restaurant, or QSR, chain in the United States by systemwide sales, with $11.1 billion in 2021, narrowly edging Burger King ($10.3 billion) and clocking in well behind wide-moat McDonald's ($45.7 billion). After divestitures of Tim Hortons (2006) and Arby's (2011), the firm manages just the burger banner, generating sales across a footprint that spans almost 7,000 total units in 30 countries. Wendy's generates revenue from the sale of hamburgers, chicken sandwiches, salads, and fries throughout its company-owned footprint, through franchise royalty and marketing fund payments remitted by its franchisees, which account for 94% of stores, and through franchise flipping and advisory fees.
Read more on WEN →
